1. Home
  2. NTRA vs ROK Comparison

NTRA vs ROK Comparison

Compare NTRA & ROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$325.66

Market Cap

47.0B

Sector

Health Care

ML Signal

HOLD

Logo Rockwell Automation Inc.

ROK

Rockwell Automation Inc.

HOLD

Current Price

$434.12

Market Cap

51.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
ROK
Founded
2003
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
47.0B
51.0B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
NTRA
ROK
Price
$325.66
$434.12
Analyst Decision
Strong Buy
Buy
Analyst Count
15
16
Target Price
$259.07
$406.20
AVG Volume (30 Days)
1.3M
662.6K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
1.38%
EPS Growth
0.65
N/A
EPS
N/A
9.44
Revenue
$210,939,000.00
$6,666,000,000.00
Revenue This Year
$18.08
$7.46
Revenue Next Year
$19.65
$6.06
P/E Ratio
N/A
$45.52
Revenue Growth
N/A
5.62
52 Week Low
$157.43
$333.13
52 Week High
$343.18
$497.36

Technical Indicators

Market Signals
Indicator
NTRA
ROK
Relative Strength Index (RSI) 60.52 43.58
Support Level $187.64 $418.84
Resistance Level $326.03 $438.72
Average True Range (ATR) 10.69 8.63
MACD -2.34 -0.15
Stochastic Oscillator 48.27 35.96

Price Performance

Historical Comparison
NTRA
ROK

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ROK Rockwell Automation Inc.

With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software and control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.

Share on Social Networks: